 |
市場調査レポート
商品コード
1084607
生体吸収性血管スキャフォールド市場：規模、シェア、見通し、機会分析（2022年～2028年）Bioresorbable Vascular Scaffold Market - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028 |
||||||
● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。 詳細はお問い合わせください。
価格
| 生体吸収性血管スキャフォールド市場：規模、シェア、見通し、機会分析（2022年～2028年） |
|
出版日: 2022年05月07日
発行: Coherent Market Insights
ページ情報: 英文 158 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
概要
当レポートでは、世界の生体吸収性血管スキャフォールド市場について調査し、市場の概要とともに、製品タイプ別、材料タイプ別、用途別、エンドユーザー別、地域別の動向、および市場に参入する企業のプロファイルなどを提供しています。
目次
第1章 調査目的・前提条件
第2章 市場の展望
- レポートの説明
- エグゼクティブサマリー
- 市場内訳：製品タイプ別
- 市場内訳：材料タイプ別
- 市場内訳：用途別
- 市場内訳：エンドユーザー別
- 市場内訳：地域別
- コヒーレントオポチュニティマップ（COM）
第3章 市場力学、規制、および動向分析
- 市場力学
- 促進要因
- 抑制要因
- 市場の機会
- 市場動向
- 影響分析
- 主なハイライト
- PEST分析
- 価格分析
- ブランド分析
- 規制の枠組み
- ポーターの分析
- 合併と買収
- 技術の進歩
- 疫学
第4章 世界の生体吸収性血管スキャフォールド市場：製品タイプ別、2017年～2028年、（100万米ドル）
- イントロダクション
- 合成
- 生物学的
第5章 世界の生体吸収性血管スキャフォールド市場：材料タイプ別、2017年～2028年、（100万米ドル）
- イントロダクション
- 金属ベース
- ポリマーベース
第6章 世界の生体吸収性血管スキャフォールド市場：用途別、2017年～2028年、（100万米ドル）
- イントロダクション
- 冠状動脈ステント
- 末梢動脈ステント
- その他
第7章 世界の生体吸収性血管スキャフォールド市場：エンドユーザー別、2017年～2028年、（100万米ドル）
- イントロダクション
- 病院
- 外来手術センター
- 心臓センター
- その他
第8章 世界の生体吸収性血管スキャフォールド市場：地域別、2017年～2028年、（100万米ドル）
- イントロダクション
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第9章 競合情勢
- ヒートマップ分析
- 企業プロファイル
- AngioDynamics, Inc.
- CR Bard, Inc.
- Teleflex Incorporated
- B. Braun Melsungen AG
- Medtronic Plc
- Vygon Ltd.
- Cook Medical Inc.
- Argon Medical Devices, Inc.
- ICU Medical, Inc.
- Theragenics Corporation
- アナリストの見解
第10章 セクション
目次
Product Code: CMI2471
Bioresorbable vascular scaffold (BVS) is a nonmetallic mesh tube, which is used to treat blocked arteries. It is similar to a stent but gradually dissolves once the blocked artery starts functioning naturally again, enabling the artery to return to its natural state. The scaffold disappears in around 12-24 months and supports the vessel until it gain its full function. BVS is designed to help open up a blocked artery in the heart and restore blood flow to the heart muscle. It is used by patients who are suffering from different types of cardiovascular diseases. Some of the commonly used BVS for cardiac procedures include Poly-L-Lactide (PLLA) bioresorbable scaffold, metallic bioresorbable scaffold, and hybrid bioresorbable scaffold.
Market Dynamics
Increasing demand for bioresorbable vascular scaffold owing to high prevalence of coronary heart disease, ischemic heart disease, and other cardiovascular diseases is expected to drive market growth. According to American Heart Association Council, in 2015, cardiovascular disease was the leading cause of death in the world, accounting for over 17.9 million deaths per year globally, and this number is expected to increase to over 23.6 million by 2030. From the same source, cardiovascular diseases accounted for nearly 836,546 deaths in the U.S. in 2015, which is about 1 of every 3 deaths.
Moreover, key players are opting for different strategies such as new product launches, FDA approvals, partnerships, and collaborations to increase its foothold in the market. For instance, in July 2016, Abbott received the U.S. Food and Drug Administration approval for Absorb bioresorbable heart stent. This device is first-of-its-kind medical device with fully dissolving heart stents. This device will be available to treat people with coronary artery disease in the U.S.
However, preference for vascular graft devices for angioplasty and coronary artery diseases is one of the major factors restraining growth of the global bioresorbable vascular scaffold market. Furthermore, stringent regulatory scenario has also obstructed growth of the market.
Key features of the study:
- This report provides in-depth analysis of the bioresorbable vascular scaffold market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period (2022-2028), considering 2021 as the base year
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players
- It profiles leading players in the global bioresorbable vascular scaffold market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key players covered as a part of this study include Abbott Laboratories, Cook Medical, Boston Scientific Corporation, Stentys SA, MAQUET Holding B.V. & Co. KG (Getinge AB), W.L. Gore & Associates, Medtronic, C. R. Bard, Inc., B. Braun Melsungen AG, and Terumo Corporation among others
- Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
- The global bioresorbable vascular scaffold market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for bioresorbable vascular scaffold market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
- Global Bioresorbable Vascular Scaffold Market, By Product Type:
- Synthetic
- Biological
- Global Bioresorbable Vascular Scaffold Market, By Material Type:
- Metal based BVS
- Polymer based BVS
- Global Bioresorbable Vascular Scaffold Market, By Application
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- Global Bioresorbable Vascular Scaffold Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- Global Bioresorbable Vascular Scaffold Market, By Geography:
- North America
- By Product Type:
- Synthetic
- Biological
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- U.S.
- Canada
- Latin America
- By Product Type:
- Synthetic
- Biological
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Synthetic
- Biological
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Synthetic
- Biological
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Synthetic
- Biological
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Synthetic
- Biological
- By Material:
- Metal based BVS
- Polymer based BVS
- By Application:
- Coronary Artery Stents
- Peripheral Artery Stents
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Cardiac Centers
- Others
- By Country:
- South Africa
- Central Africa
- North Africa
- North America
- Company Profiles
- Abbott Laboratories*
- Company Overview
- Product Portfolio
- Financial Performance
- Key Highlights
- Market Strategies
- Cook Medical
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Medtronic Plc
- Stentys SA
- MAQUET Holding B.V. & Co. KG (Getinge AB)
- W.L. Gore & Associates
- C. R. Bard, Inc.,
- Theragenics Corporation
- Abbott Laboratories*
"*" marked represents similar segmentation in other categories in the respective section.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Product Type
- Market Snippet, By Material Type
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- Impact Analysis
- Key Highlights
- PEST Analysis
- Pricing Analysis
- Brand Analysis
- Regulatory Framework
- PORTER's Analysis
- Mergers and Acquisitions
- Technological Advancements
- Epidemiology
4. Global Bioresorbable Vascular Scaffold Market, By Product Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Synthetic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Biological
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
5. Global Bioresorbable Vascular Scaffold Market, By Material Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Metal based BVS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Polymer based BVS
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
6. Global Bioresorbable Vascular Scaffold Market, By Application, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Coronary Artery Stents
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Peripheral Artery Stent
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
7. Global Bioresorbable Vascular Scaffold Market, By End User, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Cardiac center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
8. Global Bioresorbable Vascular Scaffold Market, By Region, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Regions, 2017 - 2028
- North America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application , 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application , 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application , 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application , 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of APAC
- Middle East
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application , 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Product Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Material, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Application , 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By End User, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Country, 2017 - 2028, (US$ Mn)
- South Africa
- Central Africa
- North Africa
9. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- AngioDynamics, Inc.*
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- C. R. Bard, Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Teleflex Incorporated
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- B. Braun Melsungen AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Medtronic Plc
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vygon Ltd.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Cook Medical Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Argon Medical Devices, Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- ICU Medical, Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Theragenics Corporation
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Analyst Views
10. Section
- References
- Research Methodology
- About Us and Sales Contact
